Indications |
Oral Rheumatoid arthritis Adult: 15 mg daily as a single dose. Patients with increased risk of adverse effects: Initially 7.5 mg. Elderly: 7.5 mg daily for long-term treatment. Oral Ankylosing spondylitis Adult: 15 mg daily as a single dose. Patients with increased risk of adverse effects: Initially 7.5 mg. Elderly: 7.5 mg daily for long-term treatment. Oral Acute exacerbations of osteoarthritis Adult: 7.5 mg daily up to a max of 15 mg as a single dose. Elderly: 7.5 mg daily. Oral Juvenile rheumatoid arthritis Child: ≥2 yr: 125 mcg/kg ocne daily. Max dose: 7.5 mg daily. Rectal Ankylosing spondylitis Adult: 15 mg daily as a single dose. Patient with increased risk of adverse effects: Initially 7.5 mg. Limit use to the shortest time possible. Elderly: 7.5 mg daily. Limit use to the shortest time possible. Rectal Rheumatoid arthritis Adult: 15 mg daily as a single dose. Patient with increased risk of adverse effects: Initially 7.5 mg. Limit use to the shortest time possible. Elderly: 7.5 mg daily. Limit use to the shortest time possible. Rectal Acute exacerbations of osteoarthritis Adult: 7.5 mg daily up to a max of 15 mg daily as a single dose. Limit use to the shortest time possible. Elderly: 7.5 mg daily. Limit use to the shortest time possible. Special Populations: In patients with an increased risk of adverse reactions: Initially, 7.5 mg daily. Dialysis patients: Max daily dose of 7.5 mg. |
Contraindications |
Hypersensitivity to meloxicam, aspirin or other NSAIDs; severe hepatic impairment; bleeding disorders; renal failure without dialysis. Rectal admin in patients with proctitis, haemorrhoids or rectal bleeding. |
Warnings / Precautions |
History of GI disease, asthma, hypertension, CVD or risk factors, fluid retention or heart failure. Monitor patients with advanced renal disease. May impair ability to drive or operate machinery. Elderly. Pregnancy (avoid in the 3rd trimester) and lactation. |
Adverse Reactions |
Dyspepsia, headache, nausea, diarrhoea, upper respiratory tract infection, abdominal pain, dizziness, oedema, flatulence, influenza-like symptoms, back pain, muscle spasms, musculoskeletal pain, rash, anaemia. GI perforation, ulceration and/or bleeding. In children: Abdominal pain, vomiting, diarrhoea, headache, pyrexia. Potentially Fatal: Stevens Johnson syndrome, thrombocytopenia, interstitial nephritis and idiosyncratic liver abnormality. |
Overdose Reactions |
Symptoms: Lethargy, drowsiness, nausea, vomiting, epigastric pain. Severe symptoms e.g. apnoea, metabolic acidosis, coma, nystagmus, seizures, leukocytosis, renal failure may occur. Management: Supportive and symptomatic. Multiple doses of charcoal may be needed; cholestyramine increases meloxicam clearance. Not dialysable. |
Drug Interactions |
May reduce effects of antihypertensives. Increased clearance with bile acid sequestrants e.g. colestyramine. Increased risk of renal failure with diuretics; may reduce natriuretic effects of furosemide and thiazides. May increase toxicity of methotrexate. Potentially Fatal: May increase plasma concentrations and toxicity of lithium. Increased risk of severe GI effects with aspirin, warfarin. See Below for More meloxicam Drug Interactions |
Food Interactions |
Avoid herbal preparations or food with antiplatelet activity e.g. alfalfa, anise, bilberry, bladderwrack, bromelain, cat's claw, celery, coleus, cordyceps, dong quai, evening primrose, feverfew, fenugreek, garlic, ginger, ginkgo biloba, red clover, horse chestnut, grapeseed, green tea, ginseng, guggul, horse chestnut seed, horseradish, licorice, prickly ash, red clover, reishi, sweet clover, turmeric, white willow. |
Mechanism of Actions |
Meloxicam inhibits prostaglandin synthesis by reducing cyclooxygenase enzyme activity. This results in decreased production of prostaglandin precursors. Absorption: Well absorbed from the GI tract (oral). Distribution: Protein-binding: 99%. Metabolism: Extensively hepatic via oxidation pathway. Excretion: Via urine and faeces (as inactive metabolites); 20 hr (elimination half-life). |
Administration |
May be taken with or without food. (May be taken w/ meals if GI discomfort occurs.) |
Storage Conditions |
Oral: Store at 25°C (77°F). |
ATC Classification |
M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, oxicams. |
Storage |
Oral: Store at 25°C (77°F). |
Available As |
|
Meloxicam
Post Review about Meloxicam Click here to cancel reply.
Meloxicam Containing Brands
Meloxicam is used in following diseases
Drug - Drug Interactions of Meloxicam
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.